268 related articles for article (PubMed ID: 26568517)
1. Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery.
Terracciano M; Shahbazi MA; Correia A; Rea I; Lamberti A; De Stefano L; Santos HA
Nanoscale; 2015 Dec; 7(47):20063-74. PubMed ID: 26568517
[TBL] [Abstract][Full Text] [Related]
2. Gold decorated porous biosilica nanodevices for advanced medicine.
Terracciano M; Napolitano M; De Stefano L; De Luca AC; Rea I
Nanotechnology; 2018 Jun; 29(23):235601. PubMed ID: 29553482
[TBL] [Abstract][Full Text] [Related]
3. Internalization kinetics and cytoplasmic localization of functionalized diatomite nanoparticles in cancer cells by Raman imaging.
Managò S; Migliaccio N; Terracciano M; Napolitano M; Martucci NM; De Stefano L; Rendina I; De Luca AC; Lamberti A; Rea I
J Biophotonics; 2018 Apr; 11(4):e201700207. PubMed ID: 29144609
[TBL] [Abstract][Full Text] [Related]
4. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.
Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY
Int J Nanomedicine; 2016; 11():4799-4818. PubMed ID: 27703348
[TBL] [Abstract][Full Text] [Related]
5. Tuning drug loading and release properties of diatom silica microparticles by surface modifications.
Bariana M; Aw MS; Kurkuri M; Losic D
Int J Pharm; 2013 Feb; 443(1-2):230-41. PubMed ID: 23287775
[TBL] [Abstract][Full Text] [Related]
6. Development of Surface Chemical Strategies for Synthesizing Redox-Responsive Diatomite Nanoparticles as a Green Platform for On-Demand Intracellular Release of an Antisense Peptide Nucleic Acid Anticancer Agent.
Terracciano M; Fontana F; Falanga AP; D'Errico S; Torrieri G; Greco F; Tramontano C; Rea I; Piccialli G; De Stefano L; Oliviero G; Santos HA; Borbone N
Small; 2022 Oct; 18(41):e2204732. PubMed ID: 36089668
[TBL] [Abstract][Full Text] [Related]
7. Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma.
Thapa RK; Choi JY; Poudel BK; Hiep TT; Pathak S; Gupta B; Choi HG; Yong CS; Kim JO
ACS Appl Mater Interfaces; 2015 Sep; 7(36):20360-8. PubMed ID: 26315487
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.
Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S; Shahzad S
Appl Biochem Biotechnol; 2014 May; 173(1):36-54. PubMed ID: 24615524
[TBL] [Abstract][Full Text] [Related]
9. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
10. Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs.
Figueiredo P; Ferro C; Kemell M; Liu Z; Kiriazis A; Lintinen K; Florindo HF; Yli-Kauhaluoma J; Hirvonen J; Kostiainen MA; Santos HA
Nanomedicine (Lond); 2017 Nov; 12(21):2581-2596. PubMed ID: 28960138
[TBL] [Abstract][Full Text] [Related]
11. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy.
Wang CF; Mäkilä EM; Kaasalainen MH; Hagström MV; Salonen JJ; Hirvonen JT; Santos HA
Acta Biomater; 2015 Apr; 16():206-14. PubMed ID: 25637067
[TBL] [Abstract][Full Text] [Related]
12. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
[TBL] [Abstract][Full Text] [Related]
13. Design of Gelatin-Capped Plasmonic-Diatomite Nanoparticles with Enhanced Galunisertib Loading Capacity for Drug Delivery Applications.
Tramontano C; Miranda B; Chianese G; De Stefano L; Forestiere C; Pirozzi M; Rea I
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639096
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating peptide together with PEG-modified mesostructured silica nanoparticles promotes mucous permeation and oral delivery of therapeutic proteins and peptides.
Tan X; Zhang Y; Wang Q; Ren T; Gou J; Guo W; Yin T; He H; Zhang Y; Tang X
Biomater Sci; 2019 Jun; 7(7):2934-2950. PubMed ID: 31094367
[TBL] [Abstract][Full Text] [Related]
17. pH responsive biodegradable nanogels for sustained release of bleomycin.
Sahu P; Kashaw SK; Kushwah V; Sau S; Jain S; Iyer AK
Bioorg Med Chem; 2017 Sep; 25(17):4595-4613. PubMed ID: 28734664
[TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
19. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.
Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W
Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434
[TBL] [Abstract][Full Text] [Related]
20. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
